Varex Imaging (NASDAQ:VREX) Receives Average Rating of “Moderate Buy” from Brokerages

Varex Imaging (NASDAQ:VREX) has received a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $16.1667.

A number of research analysts have issued reports on VREX shares. Wall Street Zen lowered shares of Varex Imaging from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Zacks Research raised shares of Varex Imaging from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 13th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Varex Imaging in a research note on Wednesday.

Varex Imaging Price Performance

Shares of NASDAQ:VREX opened at $10.29 on Monday. The company has a quick ratio of 1.43, a current ratio of 3.20 and a debt-to-equity ratio of 0.67. Varex Imaging has a fifty-two week low of $6.76 and a fifty-two week high of $14.56. The firm has a 50-day simple moving average of $10.71 and a 200 day simple moving average of $11.81. The company has a market cap of $433.21 million, a PE ratio of -5.15 and a beta of 0.91.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The business had revenue of $216.00 million for the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. On average, sell-side analysts anticipate that Varex Imaging will post 0.93 EPS for the current year.

Institutional Trading of Varex Imaging

A number of institutional investors have recently made changes to their positions in the stock. Glenmede Trust Co. NA lifted its stake in shares of Varex Imaging by 15.5% in the 1st quarter. Glenmede Trust Co. NA now owns 14,202 shares of the company’s stock worth $151,000 after acquiring an additional 1,909 shares during the period. Bank of America Corp DE lifted its stake in shares of Varex Imaging by 29.9% in the 1st quarter. Bank of America Corp DE now owns 337,699 shares of the company’s stock worth $3,583,000 after acquiring an additional 77,761 shares during the period. Rice Hall James & Associates LLC lifted its stake in shares of Varex Imaging by 17.7% in the 1st quarter. Rice Hall James & Associates LLC now owns 1,274,818 shares of the company’s stock worth $13,526,000 after acquiring an additional 191,854 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Varex Imaging by 2.3% in the 1st quarter. Renaissance Technologies LLC now owns 269,100 shares of the company’s stock worth $2,855,000 after acquiring an additional 6,100 shares during the period. Finally, Sei Investments Co. lifted its stake in shares of Varex Imaging by 72.5% in the 1st quarter. Sei Investments Co. now owns 411,655 shares of the company’s stock worth $4,368,000 after acquiring an additional 173,041 shares during the period.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.